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This study investigated the comparative accuracy of a recombinant 56-kDa type-specific antigen-based rapid diagnostic test
(RDT) for scrub typhus for the detection of IgM antibodies by using conventional serology in well-characterized serum samples
from undifferentiated febrile illness patients. The RDT showed high specificity and promising comparative accuracy, with 82%
sensitivity and 98% specificity for samples defined positive at an IgM indirect immunofluorescence assay positivity cutoff titer of
>1:1,600 versus 92% and 95% at>1:6,400, respectively.
There is an urgent need for inexpensive, accurate point-of-carerapid diagnostic tests (RDTs) for scrub typhus. Clinical diag-
nosis on admission is rendered difficult by the nonspecificity of
the presenting symptoms like fever and skin rash. The presence of
an eschar at the mite inoculation site is a valuable diagnostic clue
when found in combination with a positive RDT result, with pos-
itive and negative predictive values of 84.9 and 93.0%, respec-
tively, but unfortunately, the varying occurrence of this lesion,
especially in settings where scrub typhus is endemic, limits this
approach (1). Currently, three modalities are used for the diagno-
sis of scrub typhus, i.e., culture, nucleic acid detection, and anti-
body detection. Culture of patient samples is insensitive, labori-
ous, and expensive; nucleic acid detection is accurate in the early
phase of infection, but its sensitivity falls with fever duration be-
yond 9 days (2). Antibody detection, traditionally by indirect im-
munofluorescence assay (IFA), requires skilled technicians and
expensive equipment and is limited by the problemof background
titers in settings where scrub typhus is endemic, antigen selection,
and standardization (3). The rigorous use of paired serum samples
with a 4-fold antibody titer rise required as a diagnostic end-
point has overcome some issues, but confounding factors include
preexisting antibodies and cross-reactivity. Attempts to improve
the gold standard have included combining all modalities into the
scrub typhus infection criteria (STIC) proposed for diagnostic
assay validations (2). However, the single admission endpoint ti-
ter conundrum is not yet adequately resolved. Recent Bayesian
latent class modeling (LCM) data have highlighted the low speci-
ficity of admission and paired dynamic IFA IgM titers with low
convalescent-phase titers, such as a 4-fold rise to 1:800 (1;
Cherry Lim, personal communication).
An affordable, accurate point-of-care RDT that demonstrates a
positivity cutoff at the population background antibody titer
could potentially replace the admission IFA and impact patient
management positively by guiding the administration of specific
treatment. More data on the variation of background cutoff titers
between geographical regions where scrub typhus is endemic are
required, andmore sensitive RDTs (i.e., RDTs that provide a pos-
itive result at a lower antibody titer) might be better in regions
where scrub typhus is not endemic and less sensitive RDTs that are
positive at higher cutoff titers are more useful in regions where
scrub typhus is endemic. A comparative analysis of an RDT in a
region where scrub typhus is endemic has shown improved spec-
ificity when using IgM over total antibody while maintaining sen-
sitivity (4). IgM is produced immediately after pathogen expo-
sure, with a shorter half-life in blood and lymphatics than more
pathogen-specific IgG, which is produced later and provides a
long-lasting response dependent on the previous exposure of the
individual (5). Although IgG can persist for a long time and is
thought to be more specific in paired samples, it can be associated
with higher RDT false-positivity rates in areas where scrub typhus
is endemic and the population is continuously exposed. Two im-
portant questions remain unresolved, (i) the longevity of IgM and
IgG in human scrub typhus and (ii) which isotype appears earlier
in naive and exposed populations. Nonhuman primate time
course studies have shown that IgM and IgG can appear almost
simultaneously in cynomolgus macaques (6, 7).
In this study, we evaluated a new commercial immunochro-
matographic assay-based RDT based on the Orientia tsutsuga-
mushi strain Karp, Kato, Gilliam, and TA716 recombinant 56-kD
type-specific antigen (Scrub Typhus Detect IgM rapid test; InBios
International Inc., Seattle WA, USA). Two prototype RDT ver-
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sions that use either a polyclonal antibody (PAb) or amonoclonal
antibody (MAb) as the secondary antibody for IgMdetectionwere
tested.
The InBios RDTs were performed with the same batch and lot
(800231 and NB273/52, respectively) by using serum samples (10
l of serum per test strip) according to the manufacturer’s in-
structions. Previously characterized admission serum samples
(total n  100) were used that were collected from febrile illness
patients enrolled in ethically and fully Institutional ReviewBoard-
approved prospective “causes-of-fever” studies performed in
Udon Thani in northeastern Thailand (2000 and 2001; n  85)
andKathmandu, Nepal (2008 to 2011; n 15) (8, 9). The samples
included were from confirmed scrub typhus cases (n 21) meet-
ing any of the previously defined stringent STIC, i.e., culture pos-
itivity and/or an admission IgM antibody titer of 1:12,800
and/or a 4-fold rising IgM IFA antibody titer and/or positivity
for two or more of three PCR gene targets. Murine typhus cases
with paired dynamic serology and/or quantitative PCR positivity
(n  23) and dengue cases with NS1 antigen positivity (n  5)
were included. The other cases represented patients with undiffer-
entiated febrile illness (n  51) with negative scrub typhus, mu-
rine typhus, and NS1 antigen test results (2, 10).
The IFA used pooledO. tsutsugamushiKarp, Kato, andGilliam
antigens to detect IgM antibodies with IFA slides produced by the
Australian Rickettsial Reference Laboratory (Geelong, Australia).
Patient serum samples were serially 2-fold diluted from 1:100 to
1:25,600, and the endpoint was determined by two experienced
staff members as the highest titer displaying specific fluorescence
(11). Three independent laboratory technicians read the devel-
oped RDTs blinded to each other’s results, and themajority inter-
pretation was final. Sensitivity and specificity were calculated by
using a range of IFA endpoint cutoff titers for positivity, and bi-
nomial 95% confidence intervals (CIs) were calculated. Kappa
statistics were calculated for interreader variation. Statistical anal-
ysis and logistic regression (Fig. 1) were performed by using
Stata/IC software (version 13.0; StataCorp, College Station, TX,
USA) andplotted by usingR version 3.1.1 (available at http://www
.r-project.org).
The challenges of a point-of-care RDT are comparable to those
of a single-titer admission IFA, albeit with a simplified procedure
and a clear-cut endpoint. In this study, we did not attempt to
estimate the classic diagnostic accuracy of the InBios RDT—that
would require a prospective study design—but rather attempted
to define the antibody titer associated with optimal RDT perfor-
mance in a set of characterized samples as its comparative accu-
racy. Hence, we assessed the agreement of RDT positivity rates
with a range of samples with predefined different IgM IFA admis-
sion titers. Table 1 summarizes the assay results and the respective
sensitivity and specificity values at the different IFA cutoff titers.
The proportion of RDTs with a positive result at each IFA IgM
titer increased with higher IFA IgM titers (test for trend; P 
0.001). All (100%) of the RDTs provided negative results at IFA
titers of 1:400, and all (100%) of the RDTs provided positive
results at titers of1:25,600. The results show that both versions
of the new test identify the same number of positive samples iden-
tified by IFA when the reciprocal antibody cutoff titer is high,
thereby giving 100% sensitivity. Although the tests agreewell if the
sample has a high antibody titer, the new test misses some of the
IFA-positive samples at low cutoff titers, with a subsequent reduc-
tion in sensitivity. Plotting the proportion of positive RDTs at
different IFA titers delineates a sigmoidal relationship, with in-
creasing proportions of RDT positivity at titers of1:3,200 (Fig.
1). This response was comparable to that of the previously as-
sessed PanBio RDT (12). There was a minimal difference between
FIG 1 Relationship between IFA titers and RDT positivity. Shown are the
proportions of positive RDTs at different IFA titers plotted on a logarithmic
scale. Logistic regression was used to describe the sigmoidal relationship be-
tween RDT positivity and IFA titers, illustrating the low proportions of RDT
positivity at IFA titers of1:3,200. No significant difference between the two
RDT versions was observed (secondary PAb detection, red; secondary MAb
detection, blue).
TABLE 1 Summary of characterized patient admission serum samples
and RDT performance in this studya
IFA reciprocal titer cutoff
(no. of samples/100 with
IFA IgM titer cutoff) and
RDT version
No. of RDT
resultsb
% Sensitivity
(95% CI)
% Specificity
(95% CI)TP FP FN TN
400 (27)
PAb 14 2 13 71 52 (32–71) 97 (90–100)
MAb 14 3 13 70 52 (32–71) 96 (88–99)
1,600 (17)
PAb 14 2 3 81 82 (57–96) 98 (92–100)
MAb 14 3 3 80 82 (57–96) 96 (90–99)
6,400 (13)
PAb 12 4 1 83 92 (64–100) 95 (89–99)
MAb 12 5 1 82 92 (64–100) 94 (87–98)
25,600 (11)
PAb 11 5 0 84 100 (72–100) 94 (87–98)
MAb 11 6 0 83 100 (72–100) 93 (86–97)
a The results shown are stratified by IFA IgM antibody positivity titers (horizontal
rows) with corresponding InBios RDT diagnostic accuracies reported separately for
IgM detection modalities, PAb versus MAb. Although the number of characterized
samples with confirmed scrub typhus was 21/100, more samples had low IFA IgM
positivity, i.e., of all of the samples, if an IFA cutoff titer of1:400 was chosen, then 14
of these were true positives and 13 were false negatives—with rising IFA IgM titers, the
rate of false negativity decreased.
b RDT results: TP, true positive; FP, false positive; FN, false negative; TN, true negative.
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the two secondary-antibody versions in terms of the proportions
positive at the different IFA titers. The interpretation of bands was
perceived to be more difficult because of weaker, paler, and more
smeared bands in positive samples when using RDTs based on
MAbs versus RDTs based on PAbs, which was reflected by a mar-
ginally higher kappa value of 0.97 of the high antigen density ver-
sion than the 0.93 of the low-density version, respectively (data
not shown).
The RDTs assessed in this study were specific and sensitive for
the detection of high IFA titer samples only. This RDT would
therefore be expected to performwell in areas where scrub typhus
is endemic, where a higher background antibody titer would be
expected in the population, as low titers would result in a negative
RDT result and higher titers would be detected with good diag-
nostic accuracy.
It is noteworthy that a 64-fold difference in IgM antibody
concentrations exists between the samples with titers of 1:400 and
1:25,600. In samples with a low IFA titer (1:400), the RDT
results were generally negative, contributing to a high specificity.
It is not known if the antibodies in serum samples with an IFA titer
of 1:400 are different from the antibodies in samples with a
1:25,600 titer in either affinity or target. However, we have shown
in recent Bayesian LCM analyses that paired dynamic IFA IgM
titers with low convalescent-phase titers, such as a4-fold rise to
1:800, contribute to the low specificity of the IFA assay, and
therefore a higher endpoint cutoff positivity titer needs to be con-
sidered (1; Lim, personal communication).
The choice of an IFA positivity cutoff endpoint titer of 1:400
over 1:1,600 to 1:6,400 results in a stepwise improvement of the
InBios RDT’s diagnostic accuracy, with sensitivities (95% CIs)
ranging from 52% (32 to 71%) over 82% (57 to 96%) to 92% (64
to 100%) while retaining a specificity of94% (Table 1). The size
of the study data set did not allow for in-depth and detailed anal-
yses; however, it can be safely assumed that the positivity cutoff
titer of the InBios RDT lies around the 1:1,600-to-1:3,200 titer
range.
The RDT under evaluationmay have benefited from the inclu-
sion of antigenically disparate recombinant immunodominant
56-kDa antigens from four O. tsutsugamushi strains, three more
than the PanBio IgM RDT and one more than the reference IFA,
the additionalO. tsutsugamushiTA716 strain. A study limitation is
that the benefit of a broader antigen spectrum covered by the RDT
would have gone unnoticed in the present evaluation, as anti-
TA716 antibodies would not have been detected by the IFA used
(based on the Karp, Gilliam, and Kato strains), which would have
increased the RDT’s false-positivity rate because of false-negative
IFA results.
In conclusion, the InBios RDTs tested here show promising
performance characteristics for use in zones where scrub typhus is
endemic, where the admission IgM IFA positivity cutoff titer
would lie around 1:1,600 to 1:3,200. The RDT assay based on
endpoint detection with a PAb is preferable for a prospective eval-
uation. Attention should be given to understandingwhy the RDTs
are negative at a cutoff of1:400 and how this can be improved to
develop tests for use where scrub typhus is not endemic.
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